StockData
EoCene Ltd. logo

EoCene Ltd. (EOCN) shareholders

EOCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 31, 2026Score 5/30
$2.46−0.07 (-2.77%)

Close on Nov 17, 2026Market cap $2.46MP/E –Yield –

Ownership

Who owns EoCene's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Allen BaharaffChief Executive Officer, Director100,0181.52%Mar 18, 2026
Guy NehemyaChief Operating Officer25,0000.38%Mar 18, 2026
Yohai StenzlerChief Accounting Officer25,0000.38%Mar 18, 2026
Doron Leib CohenChief Financial Officer2,0830.03%Mar 18, 2026
Brueck Liat NissimovChief Scientific Officer––Mar 18, 2026
Amir PoshinskiDirector12,5000.19%Mar 18, 2026
Carol L. BrosgartDirector––Mar 18, 2026
Shmuel NirDirector12,5000.19%Mar 18, 2026
David SidranskyDirector1,0420.02%Mar 18, 2026

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
1.02%
0M shares short
Days to cover
1.3
At 0M shares a day
Change since last report
+11.7%
From 0M shares
Short volume, 20 days
29.5%
Of volume reported to FINRA

Shares sold short, last 2 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of EoCene's stock actually held short. Settlement fails (shares not delivered on time) peaked at 2,750 shares on Sep 29, 2026 over the last 90 days.

See a number that looks wrong?